NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora

Steinman, 1996, Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system, Cell, 85, 299, 10.1016/S0092-8674(00)81107-1 Coffman, 2006, Origins of the TH1-TH2 model: a personal perspective, Nat Immunol, 7, 539, 10.1038/ni0606-539 Langrish, 2005, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, J Exp Med, 201, 233, 10.1084/jem.20041257 Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat Immunol, 6, 1123, 10.1038/ni1254 Park, 2005, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nat Immunol, 6, 1133, 10.1038/ni1261 Steinman, 2007, A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage, Nat Med, 13, 139, 10.1038/nm1551 Bettelli, 2007, TH-17 cells in the circle of immunity and autoimmunity, Nat Immunol, 8, 345, 10.1038/ni0407-345 Yamamura, 2007, Interleukin 17-producing T-helper cells and autoimmune diseases: time for a paradigm shift?, Curr Rheumatol Rep, 9, 93, 10.1007/s11926-007-0001-6 Ivanov, 2006, The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035 Kebir, 2007, Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, Nat Med, 13, 1173, 10.1038/nm1651 Hafler, 2007, Risk alleles for multiple sclerosis identified by a genomewide study, N Engl J Med, 357, 851, 10.1056/NEJMoa073493 Marrie, 2004, Environmental risk factors in multiple sclerosis aetiology, Lancet Neurol, 3, 709, 10.1016/S1474-4422(04)00933-0 Ascherio, 2007, Environmental risk factors for multiple sclerosis. Part I: the role of infection, Ann Neurol, 61, 288, 10.1002/ana.21117 Ascherio, 2007, Environmental risk factors for multiple sclerosis. Part II: noninfectious factors, Ann Neurol, 61, 504, 10.1002/ana.21141 Nieuwenhuis, 2000, Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli, Arthritis Rheum, 43, 2583, 10.1002/1529-0131(200011)43:11<2583::AID-ANR28>3.0.CO;2-U Danese, 2004, Inflammatory bowel disease: the role of environmental factors, Autoimmun Rev, 3, 394, 10.1016/j.autrev.2004.03.002 Umetsu, 2002, Asthma: an epidemic of dysregulated immunity, Nat Immunol, 3, 715, 10.1038/ni0802-715 Falk, 1998, Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology, Microbiol Mol Biol Rev, 62, 1157, 10.1128/MMBR.62.4.1157-1170.1998 Butler, 2000, Antibody repertoire development in fetal and newborn piglets. III Colonization of the gastrointestinal tract selectively diversifies the preimmune repertoire in mucosal lymphoid tissues, Immunology, 100, 119, 10.1046/j.1365-2567.2000.00013.x Tannock, 2001, Molecular assessment of intestinal microflora, Am J Clin Nutr, 73, 410S, 10.1093/ajcn/73.2.410s Mazmanian, 2005, An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system, Cell, 122, 107, 10.1016/j.cell.2005.05.007 Yamamura, 2007, Understanding the behavior of invariant NKT cells in autoimmune diseases, J Neuroimmunol, 191, 8, 10.1016/j.jneuroim.2007.09.014 Treiner, 2003, Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1, Nature, 422, 164, 10.1038/nature01433 Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J: CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 190: 1215–1226 Cui, 1997, Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors, Science, 278, 1623, 10.1126/science.278.5343.1623 Bashir, 2004, Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy, J Immunol, 172, 6978, 10.4049/jimmunol.172.11.6978 Chambers, 2005, General Consideration of Antimicrobial Therapy, 1095 Yokoi, 2007, ‘FloraArray’ for screening of specific DNA probes representing the characteristics of a certain microbial community, FEMS Microbiol Lett, 273, 166, 10.1111/j.1574-6968.2007.00799.x Ochi, 2006, Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25− LAP+ T cells, Nat Med, 12, 627, 10.1038/nm1408 Worbs, 2006, Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells, J Exp Med, 203, 519, 10.1084/jem.20052016 Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Treiner, 2006, CD1d- and MR1-restricted invariant T cells: of mice and men, Curr Opin Immunol, 18, 519, 10.1016/j.coi.2006.07.001 Croxford, 2006, Invariant Vα19i T cells regulate autoimmune inflammation, Nat Immunol, 7, 987, 10.1038/ni1370 Miyake, 2005, Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases, Curr Drug Targets-Immune, Endocrine, and Metabolic Disorders, 5, 315, 10.2174/1568008054863772 Kronenberg, 2005, Toward an understanding of NKT cell biology: progress and paradoxes, Ann Rev Immunol, 23, 877, 10.1146/annurev.immunol.23.021704.115742 Terabe, 2007, NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis, Trends Immunol, 28, 491, 10.1016/j.it.2007.05.008 Rachitskaya, 2008, Cutting edge: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion, J Immunol, 180, 5167, 10.4049/jimmunol.180.8.5167 Fina, 2008, Regulation of gut inflammation and th17 cell response by interleukin-21, Gastroenterology, 134, 1038, 10.1053/j.gastro.2008.01.041 Korn, 2007, IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells, Nature, 448, 484, 10.1038/nature05970 McGeachy, 2008, Th17 cell differentiation: the long and winding road, Immunity, 28, 445, 10.1016/j.immuni.2008.03.001 Popovic, 2002, Inhibition of autoimmune encephalomyelitis by a tetracycline, Ann Neurol, 51, 215, 10.1002/ana.10092 Miyamoto, 2001, A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells, Nature, 413, 531, 10.1038/35097097 Niedergang, 2005, New trends in antigen uptake in the gut mucosa, Trends Microbiol, 13, 485, 10.1016/j.tim.2005.08.001 Turnbull, 2005, Intestinal dendritic cell subsets: differential effects of systemic TLR4 stimulation on migratory fate and activation in vivo, J Immunol, 174, 1374, 10.4049/jimmunol.174.3.1374 Bimczok, 2005, Site-specific expression of CD11b and SIRPα (CD172a) on dendritic cells: implications for their migration patterns in the gut immune system, Eur J Immunol, 35, 1418, 10.1002/eji.200425726 Coquet, 2007, IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production, J Immunol, 178, 2827, 10.4049/jimmunol.178.5.2827 Ouyang, 2008, The biological functions of T helper 17 cell effector cytokines in inflammation, Immunity, 28, 454, 10.1016/j.immuni.2008.03.004 Coquet, 2008, Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis, J Immunol, 180, 7097, 10.4049/jimmunol.180.11.7097 Coombes, 2007, A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid dependent mechanism, J Exp Med, 204, 1757, 10.1084/jem.20070590 Serada, 2008, IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis, Proc Natl Acad Sci USA, 105, 9041, 10.1073/pnas.0802218105 Bach, 2005, Infections and autoimmune diseases, J Autoimmun, 25, 74, 10.1016/j.jaut.2005.09.024 Rook, 2005, Microbes, immunoregulation, and the gut, Gut, 54, 317, 10.1136/gut.2004.053785